Candriam Luxembourg S.C.A. Cuts Stake in Msci Inc (MSCI)
Candriam Luxembourg S.C.A. lessened its stake in shares of Msci Inc (NYSE:MSCI) by 11.5% in the fourth quarter, Holdings Channel reports. The institutional investor owned 5,944 shares of the technology company’s stock after selling 772 shares during the quarter. Candriam Luxembourg S.C.A.’s holdings in Msci were worth $876,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently bought and sold shares of MSCI. JPMorgan Chase & Co. grew its stake in shares of Msci by 2.9% in the third quarter. JPMorgan Chase & Co. now owns 554,798 shares of the technology company’s stock valued at $98,428,000 after buying an additional 15,474 shares in the last quarter. Bank of New York Mellon Corp grew its stake in shares of Msci by 34.2% in the third quarter. Bank of New York Mellon Corp now owns 926,585 shares of the technology company’s stock valued at $164,385,000 after buying an additional 235,998 shares in the last quarter. American International Group Inc. grew its stake in shares of Msci by 5.5% in the third quarter. American International Group Inc. now owns 33,771 shares of the technology company’s stock valued at $5,991,000 after buying an additional 1,759 shares in the last quarter. CIBC World Markets Inc. grew its stake in shares of Msci by 48.8% in the third quarter. CIBC World Markets Inc. now owns 12,352 shares of the technology company’s stock valued at $2,191,000 after buying an additional 4,053 shares in the last quarter. Finally, Ontario Teachers Pension Plan Board grew its stake in shares of Msci by 89.9% in the third quarter. Ontario Teachers Pension Plan Board now owns 4,656 shares of the technology company’s stock valued at $826,000 after buying an additional 2,204 shares in the last quarter. Institutional investors own 93.47% of the company’s stock.
A number of brokerages have recently weighed in on MSCI. Zacks Investment Research raised Msci from a “hold” rating to a “buy” rating and set a $193.00 price objective for the company in a research note on Tuesday, February 5th. UBS Group reaffirmed a “buy” rating and issued a $196.00 price objective (up from $159.00) on shares of Msci in a research note on Friday, February 1st. Buckingham Research assumed coverage on Msci in a research note on Friday, January 25th. They set a “neutral” rating and a $171.00 target price for the company. Morgan Stanley lowered their target price on Msci from $172.00 to $159.00 and set an “equal weight” rating for the company in a research note on Tuesday, January 8th. Finally, Barclays lowered their target price on Msci from $175.00 to $165.00 and set an “overweight” rating for the company in a research note on Monday, January 7th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Msci currently has a consensus rating of “Buy” and a consensus target price of $186.56.
Msci (NYSE:MSCI) last released its earnings results on Thursday, January 31st. The technology company reported $1.31 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.30 by $0.01. Msci had a return on equity of 196.12% and a net margin of 35.42%. The firm had revenue of $361.69 million during the quarter, compared to analysts’ expectations of $360.95 million. As a group, research analysts forecast that Msci Inc will post 6.01 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Friday, February 22nd were issued a dividend of $0.58 per share. This represents a $2.32 dividend on an annualized basis and a yield of 1.20%. The ex-dividend date of this dividend was Thursday, February 21st. Msci’s dividend payout ratio (DPR) is 43.36%.
In other Msci news, insider Scott A. Crum sold 19,000 shares of Msci stock in a transaction dated Friday, February 15th. The stock was sold at an average price of $175.14, for a total transaction of $3,327,660.00. Following the completion of the sale, the insider now directly owns 96,999 shares of the company’s stock, valued at approximately $16,988,404.86. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 3.10% of the stock is owned by insiders.
ILLEGAL ACTIVITY WARNING: This news story was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this news story can be accessed at https://www.watchlistnews.com/candriam-luxembourg-s-c-a-cuts-stake-in-msci-inc-msci/2923065.html.
Msci Company Profile
MSCI Inc, together with its subsidiaries, provides investment decision support tools for the clients to manage their investment processes worldwide. The company operates through four segments: Index, Analytics, ESG, and Real Estate. The Index segment primarily provides equity indexes for use in various areas of the investment process, including index-linked product creation and performance benchmarking, as well as portfolio construction and rebalancing, and asset allocation.
Read More: Dividend
Want to see what other hedge funds are holding MSCI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Msci Inc (NYSE:MSCI).
Receive News & Ratings for Msci Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Msci and related companies with MarketBeat.com's FREE daily email newsletter.